Stock listing
NUVB Stock Price, News, Filings & Events — Nuvation Bio Inc.
Selected listing: NUVB · NYSE · USD · US
This page tracks Nuvation Bio Inc.'s NUVB:NYSE listing on NYSE in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NUVB:NYSE. NUVB:NYSE is the stock-level entry point for investors researching Nuvation Bio Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Nuvation Bio Inc. is a public company traded under the ticker NUVB in the American market. The company has a market capitalization of approximately $2.24 billion. Nuvation Bio focuses on developing innovative therapies to improve patient outcomes.
- Ticker
- NUVB:NYSE
- Asset type
- Stock
- Market cap
- $2.44B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NYSE
- Currency
- USD
Nuvation Bio Inc. NUVB:NYSE stock context
This page tracks Nuvation Bio Inc.'s NUVB:NYSE listing on NYSE in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NUVB:NYSE. NUVB:NYSE is the stock-level entry point for investors researching Nuvation Bio Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Nuvation Bio Inc. is a public company traded under the ticker NUVB in the American market. The company has a market capitalization of approximately $2.24 billion. Nuvation Bio focuses on developing innovative therapies to improve patient outcomes.
Latest news from Nuvation Bio Inc.
Nuvation Bio Granted FDA Fast Track Designation for Safusidenib for Treatment of IDH1-Mutant Glioma
August 20, 2026
Nuvation Bio to Present New Subgroup Analyses of Pivotal Data for IBTROZI® (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung ...
August 4, 2026
Nuvation Bio to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026
July 22, 2026
Nuvation Bio Announces Positive Updated Phase 2 Data and Expansion of Safusidenib Clinical Program with Two New Studies to Explore Broad ...
July 20, 2026
Nuvation Bio Inc. Announces Full Exercise of Greenshoe Option in $287.5 Million Convertible Senior Notes Offering
July 6, 2026
Nuvation Bio Inc. earnings calls
Nuvation Bio Inc. (NUVB) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Nuvation Bio Inc. (NUVB) Q1 2026 Earnings Call
May 4, 2026 · Replay with transcript and chapters
Nuvation Bio Inc. (NUVB) Q3 2025 Earnings Call
November 3, 2025 · Replay with transcript and chapters
Nuvation Bio Inc. (NUVB) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Nuvation Bio Inc. (NUVB) Q1 2025 Earnings Call
May 7, 2025 · Replay with transcript and chapters
Research Nuvation Bio Inc.
Nuvation Bio Inc. investor report
Review AI stock analysis and investor report context for NUVB:NYSE.
Nuvation Bio Inc. company profile
View the public company page for Nuvation Bio Inc. on 6ix.
Nuvation Bio Inc. news
Read company news and market updates connected to Nuvation Bio Inc..
Nuvation Bio Inc. investor events
Find investor webinars, events, and replay context for Nuvation Bio Inc..